Skip to content

Prospective Cohort Study on Alcohol-Associated Liver Disease in China

Prospective Cohort Study on Alcohol-Associated Liver Disease in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125082
Enrollment
Unknown
Registered
2026-05-21
Start date
2025-09-29
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholic fatty liver disease

Interventions

Alcoholic liver disease group:None
Normal group:None

Sponsors

Hangzhou Xixi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1.Patients presenting for diagnosis and treatment at our hospital; 2.Aged 18–74 years; 3.Able to comprehend and voluntarily sign the informed consent form; 4.Meeting the clinical diagnostic criteria for alcohol-associated fatty liver disease.

Exclusion criteria

Exclusion criteria: 1.Unable to provide informed consent; 2.Unable or unwilling to complete the procedures required by the study; 3.Currently participating in other interventional clinical trials; 4.Pregnant or lactating women; 5.Complicated with other hepatobiliary diseases, such as autoimmune liver disease,viral hepatitis, etc; 6.Complicated with severe cardiovascular and cerebrovascular diseases or renal insufficiency; 7.HIV - infected or with AIDS; 8. Received chemotherapy or alkylating agent treatment for malignant tumors within the past 2 years. 9. Other cases where the researchers consider the participant unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Liver Cirrhosis;

Countries

China

Contacts

Public ContactJianfeng Bao

Hangzhou Xixi Hospital

zjbjf1972@aliyun.com+86 571 86481822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026